Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Phase 3 Study Supports Use of Canagliflozin for Type 2 Diabetes in Children and Adolescents

A phase 3, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for treatment of type 2 diabetes mellitus (T2DM) in children and adolescents.

August 4, 2025


August 4 2025

August 3 2025

August 2 2025

August 1 2025

July 31 2025

July 30 2025

July 29 2025

July 28 2025

July 26 2025

July 25 2025

July 24 2025

July 23 2025

July 22 2025